BIONANO GENOMICS INC (BNGO:NASDAQ)
$1.23 -0.02 (-1.6%)
Analysed BIONANO GENOMICS INC (BNGO:NASDAQ) News Sources
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
26-05-2026
yahoo.com
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
28-05-2026
yahoo.com
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors
28-05-2026
yahoo.com
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
18-06-2026
yahoo.com
Bionano Announces Hiring of Chief Scientific Officer
24-06-2026
yahoo.com
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
27-07-2026
yahoo.com
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
10-08-2026
yahoo.com
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
11-08-2026
yahoo.com
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
17-08-2026
fool.com
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
24-08-2026
yahoo.com
What is the current price of BIONANO GENOMICS INC (BNGO:NASDAQ)?
The current price of BIONANO GENOMICS INC (BNGO:NASDAQ) is $1.23.
BIONANO GENOMICS INC (BNGO:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIONANO GENOMICS INC (BNGO:NASDAQ) since the previous trading day is $-0.02.
BIONANO GENOMICS INC (BNGO:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIONANO GENOMICS INC (BNGO:NASDAQ) since the previous trading day is -1.6%.
What is the most recent average sentiment score for BIONANO GENOMICS INC (BNGO:NASDAQ)?
The most recent average sentiment score for BIONANO GENOMICS INC (BNGO:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BIONANO GENOMICS INC (BNGO:NASDAQ)?
The most recent sentiment for BIONANO GENOMICS INC (BNGO:NASDAQ) is .
SEC-8K** Filing Available For BIONANO GENOMICS INC (BNGO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.